Sale!
KANAKASAVAM
$20.00 $17.99
Ayurvedic herbal supplement
ANTI ASTHMATIC TONIC
INDICATION
Widely used in the treatment of respiratory conditions such as Asthma,
cough, fever and bleeding diseases. It is a natural mucolytic and bronchodilator.
It is also in bleeding diseases, injuries and chronic fever. It helps to
relieve chest mucous congestion.
DOSAGE:
12 – 24 ml. one or two times a day, usually advised after food.
If needed, equal quantity of water can be added before consumption.
RelatedProducts
MANASA MITHRA GULIKA TABLET
ANTI STRESS SUPPLEMENT
INDICATION
Useful in depression and psychosis.
DOSAGE:
1 – 2 tablets , 1 – 2 times a day
GOROCHANADI GULIKA
Gorochanadi Gulika benefits: It is used in Ayurvedic treatment of fever,
pneumonia, cough, cold, bronchitis, asthma, diseases of throat, tonsillitis,
chronic fever.
It is also used in treating digestive disorders such as bloating, hyperacidity,
gastritis and low digestion strength.
It is also used in treatment of memory loss, impaired hearing, vision problem.
This is also good in children’s ailments.
DOSAGE
1 – 2 tablets 2 – 3 times a day, before or after food or as directed by
Ayurvedic doctor
DASAMOOLARISHTAM
Ayurvedic herbal supplement
HEALTH PROMOTER TONIC
INDICATION
Useful in indigestion, lack of taste, respiratory conditions, fistula, in diseases
of Vata imbalance, vomiting, anemia, liver diseases, skin diseases, haemorrhoids,
urinary tract conditions, cough, jaundice. It is used as a general
health tonic. It improves immunity and strength.
DOSAGE:
12 – 24 ml. one or two times a day, usually advised after food.
If needed, equal quantity of water can be added before consumption.
VETTUMARAN GULIKA TABLET
ANTIPYRECTIC AYURVEDIC SUPPLEMENT
INDICATION
fever, vomiting, abdominal colic pain
DOSAGE
1 tablet two times a day or as directed by Ayurvedic physician
KAISORA GUGGULU GULIKA TABLET
SKIN CARE SUPPLEMENT
INDICATION
Useful in aging skin health promoter, joint health, natural blood cleanser
DOSAGE:
1 – 2 tablets , 1 – 2 times a day
Reviews
There are no reviews yet.